Delaware Law: M&A Checklist

Key Takeaways

• 192-page checklist covers core Delaware M&A doctrines
• Free download available via Morris Nichols website
• Includes guidance on fiduciary duties and poison pills
• Addresses appraisal rights, preferred stock, and deal protections
• Useful for both negotiated acquisitions and hostile bids

Summary

Morris Nichols has released the 2026 edition of its 192‑page “Mergers & Acquisitions: A Delaware Checklist,” available for free download. The guide compiles the most critical Delaware court decisions on fiduciary duties, poison pills, deal protections, appraisal rights, preferred stock and other merger‑agreement provisions. It serves as a practical roadmap for both negotiated acquisitions and hostile bids. The checklist is hosted on the firm’s website and can be accessed without a subscription.

Pulse Analysis

Delaware law continues to shape the landscape of American mergers and acquisitions, with its courts setting the benchmark for fiduciary standards, defensive mechanisms and shareholder rights. Practitioners rely on precedent‑heavy guidance to navigate complex transactions, and a single, comprehensive resource can dramatically cut research time. By aggregating key decisions from the Delaware Supreme Court and Court of Chancery, the 2026 Morris Nichols checklist offers a pragmatic lens on how courts interpret poison pills, appraisal rights and the duties owed by directors during a deal.

The new checklist spans 192 pages and is organized around the most common deal‑structuring questions. It walks readers through the nuances of preferred‑stock conversions, the mechanics of deal‑protective clauses, and the procedural safeguards that trigger appraisal rights. Because the document is freely downloadable, it lowers the barrier for smaller firms and in‑house counsel to access high‑quality guidance that previously required costly subscriptions or bespoke counsel. The inclusion of recent rulings ensures that users are aligned with the latest judicial trends, from heightened scrutiny of “business purpose” defenses to evolving standards for board independence.

For the broader market, the checklist underscores a shift toward greater transparency and efficiency in M&A transactions. Companies that integrate this resource into their due‑diligence workflows can anticipate fewer post‑closing disputes and more predictable outcomes in hostile scenarios. Moreover, the free distribution model reflects a growing expectation that legal knowledge be more accessible, potentially prompting other firms to release similar tools. As deal volume rebounds in 2026, leveraging such consolidated Delaware guidance will be a competitive advantage for both buyers and sellers.